Cardiac Biomarker Study in Esophageal Cancer Patients Treated With Chemotherapy and Radiation
The goal of this clinical research study is to learn if the radiation that you will receive
for esophageal cancer may cause the heart to create more proteins called cardiac biomarkers.
When cardiac biomarkers are above normal levels, there may be heart damage. The
relationship between cardiac biomarkers and radiation therapy has not been well studied.
Learning more about this relationship may lead to better ways to check the heart during
radiation therapy and predict heart problems.
Clinical Trial Conditions: Esophageal Cancer
Treatments in this Clinical Trial : Cardiac Biomarker Blood Draws
Eligible Clinical Trial Participant Age : Between 18 years to 100 years
Can Healthy Volunteers Participate: No
Clinical Trial Lead Sponsor: M.D. Anderson Cancer Center
Detailed Clinical Trial Description: The goal of this clinical research study is to learn if the radiation that you will receive
for esophageal cancer may cause the heart to create more proteins called cardiac biomarkers.
When cardiac biomarkers are above normal levels, there may be heart damage. The
relationship between cardiac biomarkers and radiation therapy has not been well studied.
Learning more about this relationship may lead to better ways to check the heart during
radiation therapy and predict heart problems.
The clinical trial information was obtained from http://clinicaltrials.gov/ct2/show/NCT01627080
